Nitib 140 mg

Description

Nitib 140 mg (Ibrutinib)

Nitib 140 mg (Ibrutinib) contains a drug moiety known as Ibrutinib. It is the type of drug used to treat blood cancers, including mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenstrom’s macroglobulinemia.

A small drug moiety impedes β-cell multiplication and survival by irreversibly attaching the protein Bruton’s tyrosine kinase (BTK), blocking the BTK will inhibit the β-cell receptor pathway that is often abnormally active in β-cell cancers.

Nitib 140 mg (Ibrutinib) binds permanently to a protein called BTK, which is vital in β-cell. It is a medication prescribed for treating or curing adult patients with blood cancers such as Chronic Graft Versus Host Disease, Marginal zone lymphoma, Waldenstrom’s macroglobulinemia, mantle cell lymphoma, and smallpox lymphocytic lymphoma, chronic lymphocytic leukemia.

Nitib 140 mg (Ibrutinib) is the first-line treatment in people newly diagnosed with chronic lymphocytic leukemia (CLL) blood cancer and need the treatment. These capsules can also be used for chronic lymphocytic leukemia (CLL) that reverts or retreats.

Ibrutinib is an active component of the Nitib 140 mg (Ibrutinib). It works in a way that it obstructs the action of a specific protein known as Bruton’s tyrosine kinase or BTK ( a protein that is found in the β-cells) and it impels signals to the other parts of the body that help β-cells to proliferate and survive.

But these generic capsules block BTK and help eradicate and reduce the number of cancer β-cells. This stops and slows down the progression of cancer.

Administration of Nitib 140 mg (Ibrutinib)

The Ibrutinib is available as immediate-release oral capsules and immediate-release oral tablets as well. It is prescribed to take this medicine once a day at the same time every day. The dose and the duration of the treatment completely depend on the patient’s condition, age, and type of blood cancer.

Additionally, it also depends on the body’s response to the first dose of the drug. The capsules should be taken orally with a glass of water, do not open, chew and crush capsules or tablets. Moreover, do not take medication without proper consultation from the doctor.

Precautions while taking Nitib 140 mg (Ibrutinib)

• Do not take Nitib 140 mg (Ibrutinib) with grapefruit or Seville orange because this can increase the amount of Nitib in the blood.
• While treatment with Nitib 140 mg (Ibrutinib) tumor lysis disorder intermittently resulted, assess the baseline risk and take appropriate precautions.
• Pregnant women should not take it without the proper consultancy of a doctor as it may lead to fetal harm.
• While on medication with Nitib 140 mg (Ibrutinib), several cases of renal failures are recorded, so the person with kidney disorders should not take this medication without a doctor’s prescription.
• Avoid taking blood-thinning medicines with this medication.

Side effects of Nitib 140 mg (Ibrutinib)

• A hemorrhage is a commonly seen side effect during ongoing treatment of Nitib 140 mg (Ibrutinib). It can be serious and may prove lethal if not given immediate medical attention. The signs may include the following:
• Blood in stools
• Blood in vomiting
• Cough up blood
• Dizziness
• Weakness
• Severe headache
• Serious infections may also be caused by this medication.
• Decrease in blood counts, the components of blood, i.e., erythrocytes, leukocytes, and thrombocytes, may be reduced, so do the blood test monthly.
• This medication may also cause hypertension, an increase in blood pressure.
• This medication may also cause variation in pulse rate, heart rate, etc. It may lead to ventricular arrhythmias, atrial fibrillation, and flutter. It may affect the heart and may turn lethal.

Most common side effects of Nitib 140 mg (Ibrutinib)

• Diarrhea
• Fatigue
• Muscle, bone, and joint pain
• Rashes
• Bruising
• Stomatitis
• Muscle cramps
• Nausea

As the drug Nitib 140 mg (Ibrutinib) has major side effects, do not take this medicine without proper prescription and consultancy of a specialist.[/vc_column_text][/vc_column][/vc_row]